Context Therapeutics Takes Bold Step with IND Submission for Groundbreaking Cancer Therapy
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) recently announced its submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for CTIM-76. This …
Context Therapeutics Takes Bold Step with IND Submission for Groundbreaking Cancer Therapy Read More